vs

Side-by-side financial comparison of Crane NXT, Co. (CXT) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $387.7M, roughly 1.3× Crane NXT, Co.). Crane NXT, Co. runs the higher net margin — 1.7% vs -12.3%, a 14.0% gap on every dollar of revenue. Genius Sports Ltd produced more free cash flow last quarter ($69.6M vs $-24.1M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 2.3%).

Crane Co. is an American industrial products company based in Stamford, Connecticut. Founded by Richard Teller Crane in 1855, it became one of the leading manufacturers of bathroom fixtures in the United States, until 1990, when that division was sold off. In 1960 it began the process of becoming a holding company with a diverse portfolio. Its business segments are Aerospace & Electronics, Engineered Materials, Fluid Handling, and Controls. Industries served by these segments include chemical...

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

CXT vs GENI — Head-to-Head

Bigger by revenue
GENI
GENI
1.3× larger
GENI
$510.9M
$387.7M
CXT
Higher net margin
CXT
CXT
14.0% more per $
CXT
1.7%
-12.3%
GENI
More free cash flow
GENI
GENI
$93.7M more FCF
GENI
$69.6M
$-24.1M
CXT
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
2.3%
CXT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CXT
CXT
GENI
GENI
Revenue
$387.7M
$510.9M
Net Profit
$6.4M
$-63.0M
Gross Margin
40.2%
25.2%
Operating Margin
-11.5%
Net Margin
1.7%
-12.3%
Revenue YoY
17.4%
Net Profit YoY
-70.5%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXT
CXT
GENI
GENI
Q1 26
$387.7M
Q4 25
$476.9M
$510.9M
Q3 25
$445.1M
$335.4M
Q2 25
$404.4M
$215.2M
Q1 25
$330.3M
$119.7M
Q4 24
$399.1M
$413.0M
Q3 24
$403.5M
$285.8M
Q2 24
$370.6M
$184.1M
Net Profit
CXT
CXT
GENI
GENI
Q1 26
$6.4M
Q4 25
$47.5M
$-63.0M
Q3 25
$50.5M
Q2 25
$24.9M
$-47.3M
Q1 25
$21.7M
$-25.5M
Q4 24
$-85.5M
Q3 24
$47.1M
$-47.1M
Q2 24
$41.6M
$-35.5M
Gross Margin
CXT
CXT
GENI
GENI
Q1 26
40.2%
Q4 25
42.4%
25.2%
Q3 25
43.3%
24.2%
Q2 25
41.7%
19.1%
Q1 25
42.4%
10.7%
Q4 24
45.2%
16.7%
Q3 24
42.5%
20.5%
Q2 24
43.4%
18.6%
Operating Margin
CXT
CXT
GENI
GENI
Q1 26
Q4 25
16.7%
-11.5%
Q3 25
18.4%
-15.3%
Q2 25
11.8%
-21.0%
Q1 25
11.3%
-20.3%
Q4 24
17.7%
-18.0%
Q3 24
18.6%
-13.9%
Q2 24
18.2%
-16.8%
Net Margin
CXT
CXT
GENI
GENI
Q1 26
1.7%
Q4 25
10.0%
-12.3%
Q3 25
11.3%
Q2 25
6.2%
-22.0%
Q1 25
6.6%
-21.3%
Q4 24
-20.7%
Q3 24
11.7%
-16.5%
Q2 24
11.2%
-19.3%
EPS (diluted)
CXT
CXT
GENI
GENI
Q1 26
Q4 25
$0.82
Q3 25
$0.87
Q2 25
$0.43
Q1 25
$0.38
Q4 24
$1.00
Q3 24
$0.81
Q2 24
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXT
CXT
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$228.3M
$280.6M
Total DebtLower is stronger
$1.5B
Stockholders' EquityBook value
$1.2B
$724.5M
Total Assets
$3.6B
$1.1B
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXT
CXT
GENI
GENI
Q1 26
$228.3M
Q4 25
$233.8M
$280.6M
Q3 25
$182.4M
$110.2M
Q2 25
$152.5M
$110.2M
Q1 25
$173.8M
$110.2M
Q4 24
$165.8M
$100.3M
Q3 24
$165.1M
$100.3M
Q2 24
$175.5M
$100.3M
Total Debt
CXT
CXT
GENI
GENI
Q1 26
$1.5B
Q4 25
$1.0B
Q3 25
$834.3M
Q2 25
$861.8M
Q1 25
$541.1M
Q4 24
$540.6M
Q3 24
$638.2M
Q2 24
$638.9M
Stockholders' Equity
CXT
CXT
GENI
GENI
Q1 26
$1.2B
Q4 25
$1.3B
$724.5M
Q3 25
$1.2B
$572.4M
Q2 25
$1.2B
$572.4M
Q1 25
$1.1B
$572.4M
Q4 24
$1.1B
$573.0M
Q3 24
$1.1B
$573.0M
Q2 24
$989.8M
$573.0M
Total Assets
CXT
CXT
GENI
GENI
Q1 26
$3.6B
Q4 25
$3.1B
$1.1B
Q3 25
$2.9B
$792.3M
Q2 25
$2.9B
$792.3M
Q1 25
$2.4B
$792.3M
Q4 24
$2.4B
$775.7M
Q3 24
$2.4B
$775.7M
Q2 24
$2.4B
$775.7M
Debt / Equity
CXT
CXT
GENI
GENI
Q1 26
1.22×
Q4 25
0.80×
Q3 25
0.69×
Q2 25
0.73×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.60×
Q2 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXT
CXT
GENI
GENI
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$-24.1M
$69.6M
FCF MarginFCF / Revenue
-6.2%
13.6%
Capex IntensityCapex / Revenue
2.6%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXT
CXT
GENI
GENI
Q1 26
Q4 25
$105.8M
$81.9M
Q3 25
$92.0M
$-4.8M
Q2 25
$62.8M
$-1.2M
Q1 25
$-19.1M
$-14.6M
Q4 24
$81.1M
$14.9M
Q3 24
$66.7M
$-9.2M
Q2 24
$56.8M
Free Cash Flow
CXT
CXT
GENI
GENI
Q1 26
$-24.1M
Q4 25
$69.6M
Q3 25
$78.7M
$-14.2M
Q2 25
$55.8M
$-5.8M
Q1 25
$-32.2M
$-16.0M
Q4 24
$11.3M
Q3 24
$53.5M
$-11.6M
Q2 24
$47.9M
FCF Margin
CXT
CXT
GENI
GENI
Q1 26
-6.2%
Q4 25
13.6%
Q3 25
17.7%
-4.2%
Q2 25
13.8%
-2.7%
Q1 25
-9.7%
-13.4%
Q4 24
2.7%
Q3 24
13.3%
-4.1%
Q2 24
12.9%
Capex Intensity
CXT
CXT
GENI
GENI
Q1 26
2.6%
Q4 25
2.4%
Q3 25
3.0%
2.8%
Q2 25
1.7%
2.1%
Q1 25
4.0%
1.2%
Q4 24
0.9%
Q3 24
3.3%
0.9%
Q2 24
2.4%
Cash Conversion
CXT
CXT
GENI
GENI
Q1 26
Q4 25
2.23×
Q3 25
1.82×
Q2 25
2.52×
Q1 25
-0.88×
Q4 24
Q3 24
1.42×
Q2 24
1.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXT
CXT

Detection and Traceability Technologies$194.9M50%
Security and Authentication Technologies$192.8M50%

GENI
GENI

Segment breakdown not available.

Related Comparisons